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Multiple sclerosisSlowed information processing speed is commonly reported in persons with multiple sclerosis (MS), and is
typically investigated using clinical neuropsychological tests, which provide sensitive indices of mean-level
information processing speed. However, recent studies have demonstrated that within-person variability
or intra-individual variability (IIV) in information processing speed may be a more sensitive indicator of neu-
rologic status than mean-level performance on clinical tests. We evaluated the neural basis of increased IIV in
mildly affected relapsing–remitting MS patients by characterizing the relation between IIV (controlling for
mean-level performance) and white matter integrity using diffusion tensor imaging (DTI). Twenty women
with relapsing–remitting MS and 20 matched control participants completed the Computerized Test of Infor-
mation Processing (CTIP), from which both mean response time and IIV were calculated. Other clinical mea-
sures of information processing speed were also collected. Relations between IIV on the CTIP and DTI metrics
of white matter microstructure were evaluated using tract-based spatial statistics. We observed slower and
more variable responses on the CTIP in MS patients relative to controls. Signiﬁcant relations between
white matter microstructure and IIV were observed for MS patients. Increased IIV was associated with re-
duced integrity in more white matter tracts than was slowed information processing speed as measured
by either mean CTIP response time or other neuropsychological test scores. Thus, despite the common use
of mean-level performance as an index of cognitive dysfunction in MS, IIV may be more sensitive to the over-
all burden of white matter disease at the microstructural level. Furthermore, our study highlights the poten-
tial value of considering within-person ﬂuctuations, in addition to mean-level performance, for uncovering
brain–behavior relationships in neurologic disorders with widespread white matter pathology.
© 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.1. Introduction
1.1. Information processing in multiple sclerosis
Multiple sclerosis (MS) is a demyelinating disorder of the central
nervous system that is associated with neurologic and cognitive im-
pairments (e.g., (Keegan and Noseworthy, 2002)) that result in ex-
tensive societal burden (Canadian Institute of Health Information,Processing; IIV, intra-individual
and Neuroscience, Dalhousie
, Nova Scotia B3H 4R2, Canada.
).
nc. Open access under CC BY-NC-ND li2007). Cognitive dysfunction affects approximately 40–65% of MS
patients (Chiaravalloti and DeLuca, 2008; Hoffman et al., 2007; Patti
et al., 2009). Reduced information processing speed is the most
frequently reported impairment and has been hypothesized to con-
tribute to dysfunction of higher order cognitive abilities such as work-
ing memory and executive functions (DeLuca et al., 2004; Tombaugh
et al., 2010). Information processing speed in MS is typically evaluat-
ed on the basis of performance accuracy on speeded clinical neuro-
psychological tests. In particular, the Paced Auditory Serial Addition
Test (PASAT (Gronwell, 1977)) and the Symbol Digit Modalities Test
(SDMT (Smith, 1982)) are widely employed in both clinical and re-
search settings, due to their high sensitivity to dysfunction (Brochet
et al., 2008; Drake et al., 2010; Hayton et al., 2012; Rovaris et al.,
1998; Snyder and Cappelleri, 2001). Recently, computerized tasks
that measure reaction time have also been employed in MS research
with greater frequency (Reicker et al., 2007; Tombaugh et al., 2010;
Wojtowicz et al., 2012a). Poor performance, as measured by a re-
duced number of correct responses or slower mean reaction time, is
inferred to reﬂect slowed information processing.cense.
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In addition to the total number of correct responses within a given
time period or the mean-level reaction time for a speeded task,
intra-individual variability (IIV) on trials within timed tests of infor-
mation processing speed also provides insight into patients' cognitive
functioning. To understand how IIV can provide additional informa-
tion unique frommean-level performance, consider the following ex-
ample of two patients with equally slowed mean-level performance.
One patient's performance might be consistently slowed on all trials,
with approximately the same IIV as healthy controls. The other pa-
tient's responses might be more widely distributed, with both normal
and slow trials contributing to the overall slowed performance such
that IIV is increased. In this way, IIV can provide insight into perfor-
mance differences over and above mean-level measures.
Greater variability in response speed across trials within a task has
been demonstrated in populations with various neurodegenerative
disorders including Alzheimer's disease, Parkinson's disease, mild
cognitive disorders, dementia, traumatic brain injury, schizophrenia,
and attention deﬁcit and hyperactivity disorder (Anstey et al., 2007;
Burton et al., 2002; Hultsch et al., 2000; Li et al., 2001; MacDonald
et al., 2006; MacDonald et al., 2009; Manoach, 2003; Murtha et al.,
2002). Recently, relapsing–remitting MS patients have been found
to demonstrate greater IIV in performance compared to healthy con-
trols, even when potential sensorimotor confounds were controlled
(Wojtowicz et al., 2012a). IIV has also been found to better discrimi-
nate MS patients from healthy controls in comparison to mean re-
sponse time or level of performance on common clinical tests
such as the PASAT (Bodling et al., 2012; Wojtowicz et al., 2012a;
Wojtowicz et al., 2013). Thus, previous research has shown that IIV
provides unique information regarding information processing difﬁ-
culties in MS. However, while IIV is known to be associated with de-
creased white matter volume (Walhovd and Fjell, 2007) and integrity
(Fjell et al., 2011) in healthy individuals, the relation between IIV and
white matter integrity of MS patients has not yet been demonstrated.
Understanding the neural basis of increased IIV in MS could provide
important insights into the cause of this important source of disability
and provide sensitive indicators of disease progression.
1.3. White matter integrity in MS: diffusion tensor imaging
Diffusion tensor imaging (DTI) has emerged as a key MRI method-
ology for understanding white matter pathology in MS (e.g., (Rovaris
et al., 2005)). Studies have consistently reported differences in DTI
metrics between MS patients and controls, such as decreased frac-
tional anisotropy (FA) within the normal appearing white matter of
patients (NAWM; e.g., (Hasan et al., 2005; Roosendaal et al., 2009)),
reﬂecting decreased integrity of white matter tracts (Kochunov
et al., 2009; Le Bihan and Johansen-Berg, 2012). DTI appears more
sensitive to disease-related phenomena than lesion burden as seen
on conventional MRI, and relations between DTI metrics and informa-
tion processing speed in MS patients have begun to emerge in the re-
cent literature (e.g., (Dineen et al., 2009; Kern et al., 2011; Yu et al.,
2012)). For example, Yu et al. (2012) reported correlations between
reduced FA and impairment on multiple clinical neuropsychological
tests, with the strongest correlations observed for the SDMT. Howev-
er, to date only mean-level information processing speed has been
evaluated in relation to DTI.
1.4. Study objectives
The main objective of the current study was to explore the neural
basis for increased IIV in MS and in particular, its association with
white matter microstructure. We hypothesized that, in a sample of
mildly affected MS patients, IIV would be signiﬁcantly related to
white matter integrity. Given recent behavioral evidence that IIVbetter discriminates between MS patients and controls than mean re-
action time (Bodling et al., 2012; Wojtowicz et al., 2012a; Wojtowicz
et al., 2013), we further hypothesized that IIV would be more sensi-
tive to white matter microstructure than would mean reaction time
in MS patients. In addition to mean reaction time and IIV on timed
tests, we also examined MS patients' performance on the SDMT, a
commonly used clinical test of information processing speed. As
well, we examined conventional MRI measures of lesion burden and
whole brain atrophy among MS patients.
2. Material and methods
2.1. Participants
All participants provided informed consent and were compensated
for participation following procedures approved by the Capital District
Health Authority Research Ethics Board in compliancewith theDeclara-
tion of Helsinki. Twenty female participants with clinically deﬁnite re-
lapsing–remitting MS (Polman et al., 2011) were recruited from the
Dalhousie MS Research Unit, at the time of their scheduled visits to
this specialized clinic for MS care. All had been clinically stable, had
not taken corticosteroids for at least three months, and had no more
than moderate neurologic disability as assessed by the Expanded
Disability Status Scale (i.e., EDSS scores between 0 and 6 (Kurtzke,
1983)). All MS participants were receiving ﬁrst-line disease modifying
therapy for treatment of MS at the time of the study (O'Connor and
Devonshire, 2008). None had comorbid neurologic or psychiatric disor-
ders. Other exclusion criteria were a history of substance abuse, learn-
ing disability, head trauma, or seizures. MS participants with a history
of depression or anxiety disorders were included only if it was not an
active clinical problem at the time of the study, as determined by MS
clinic staff. Twenty control participants, matched for sex, age, and edu-
cation, were recruited from advertisements and word of mouth. The
same inclusion and exclusion criteria were applied to the healthy par-
ticipant group except for those related to MS. All participants reported
normal or corrected-to-normal vision at the time of the study.
2.2. Behavioral data
For behavioral data, group comparisons (two-sample t-tests) and
correlations within the MS participant group (controlling for age)
were performed in SPSS Version 20.0 (IBM Corporation, 2011). For
t-tests in which the assumption of homogeneity of variance was not
met, Levine's correction was applied.
2.2.1. Clinical measures
EDSS scores were obtained from the MS patients' medical records,
with all clinic visits occurring within two weeks of their participation
in the study. All participants completed the oral version of the SDMT
(Smith, 1982), a clinical test of information processing speed. To as-
sess whether symptoms of depression were a confounding issue, par-
ticipants also completed the Beck Depression Inventory-Fast Screen
(Beck et al., 2000).
2.2.2. CTIP
2.2.2.1. Administration. The Computerized Test of Information Process-
ing (CTIP) (Tombaugh and Rees, 2008) was used to evaluate both
mean response speed and IIV. IIV on the CTIP has been previously
shown to better discriminate MS patients from healthy controls
than mean response speed (e.g., (Wojtowicz et al., 2012a)). Partici-
pants performed the CTIP in a quiet testing room on a 15″ Apple
MacBook Pro. The CTIP includes three reaction time subtests that pro-
gressively increase in complexity and cognitive processing demands:
1) a simple reaction time (SRT) task in which participants are asked
to press the spacebar as soon as an “X” appears on the screen; 2) a
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press the right key (i.e., “/”) or the left key (i.e., “z”) when they see
the words “DUCK” or “KITE,” respectively; and 3) a semantic search
reaction time (SSRT) task in which participants are asked to decide
if a given word belongs to a particular category. On each trial of the
SSRT, one of four semantic categories is presented at random (Weapon,
Furniture, Bird, or Fruit). Two seconds later, a word appears below the
category. The participants are asked to press the right key if the word
belongs to the category and the left key otherwise. Each task includes
10 practice trials and 30 test trials, for a total duration of 10–15 min.
2.2.2.2. Analysis. Trials with incorrect responses were excluded from all
analyses. Mean reaction time was calculated for each participant for
each CTIP subtest. IIVwas calculated as the individual standard deviation
(ISD) (Wojtowicz et al., 2012a). Thismeasure controls for systematic fac-
tors that can affect variability (e.g., practice, learning effects) and ensures
that differences in variability are not a statistical artifact of differences in
individual or groupmean performance (Hultsch et al., 2000). Such unde-
sirable effects are parceled out using regression and the standardized re-
sidual scores are transformed to t-scores to calculate ISD. The data were
screened for extreme values (i.e., three SDs from the mean of each
group), which were excluded from the analyses. This represents a con-
servativemethod of calculating IIV, as removing extremevalueswill like-
ly reduce the extent of within-subject variability. Group-level mean
values were imputed for any excluded trials, which represented 1.3%,
3.3%, and 3.8% of trials for the SRT, CRT, and SSRT, respectively.
2.3. MRI data
2.3.1. Acquisition
MRI data were acquired on the same day as CTIP and SDMT admin-
istration, using a 1.5 T General Electric MRI and standard eight channel
head coil. DTI acquisition used a spin-echo echo planar imaging se-
quence. One image with no diffusion weighting was collected, followed
by 55 diffusion-weighted images with the following parameters: TR =
12 s, TE = 71.2 ms, b-value = 850 s/mm2, FOV = 260 mm2, 128 ×
128 matrix, and 45 3 mm axial slices. A T1-weighted anatomical
image was also acquired, using a spoiled gradient recalled (SPGR) se-
quence (TR / TE = 25/5 ms, 40 degree ﬂip angle, FOV = 240 mm2,
256 × 256 matrix, and 124 1.5 mm axial slices). In addition, a T2-
weighted ﬂuid-attenuated inversion recovery (FLAIR) image was
acquired (TR / TE / TI = 8000/120/2000 ms, two averages, FOV =
240 mm2, 256 × 224 matrix, and 56 3 mm axial slices).
2.3.2. Analysis
2.3.2.1. Conventional MRI. The Lesion Segmentation Toolbox (LST)
(Schmidt et al., 2012) was used to automatically identify T2
hyperintense lesions in the MS participants on the basis of a
T1-weighted and FLAIR image. Before employing LST,we ﬁrst registered
the T1-weighted and FLAIR images and resampled both images to a
common resolution (.47 × .47 × 1.5 mm3) using FMRIB Software
Library's (FSL) FLIRT (Jenkinson and Smith, 2001; Jenkinson et al.,
2002). Preliminary testing suggested that LST performed better when
this pre-processing step was performed (based on visual inspection of
the lesion segmentation results overlaid on the FLAIR images).
To evaluate lesion burden at the group level, the binary lesion
masks output by LST were transformed to standard space using a
two-step procedure. First, the FLAIR images were linearly registered
to DTI space (using the image with no diffusion weighting as the
target). This transformation was applied to the binary lesion mask.
Second, the nonlinear warp to standard space, deﬁned in the DTI
analysis (see Section 2.3.2.2), was applied to these transformed bina-
ry lesion maps. The group lesion map was computed such that voxels
in which greater than or equal to 30% of MS participants had lesions
were included (threshold based on (Yu et al., 2012)).Brain parenchymal fraction (BPF) (Phillips et al., 1998) was calcu-
lated from the partial volume estimate maps of the three tissue clas-
ses, segmented in Statistical Parametric Mapping 8 (SPM8) (The FIL
Methods Group, 2013) and its Voxel-Based Morphometry Toolbox
(VBM8) (Gaser, n.d.) after lesion ﬁlling in LST. Deﬁned as the fraction
of the combined volume of gray matter and white matter divided by
the total intracranial volume, BPF is an established technique to in-
vestigate global brain atrophy (De Stefano et al., 2007).
The relations between behavioral measures and both lesions and
BPF were evaluated, in the MS participant group only, using correla-
tion analysis in SPSS (IBM Corporation, 2011). Age was included as
a covariate of no interest.
2.3.2.2. DTI. DTI data were analyzed using FSL 5.0.2 (Smith et al., 2004).
FSL's Diffusion Toolbox was used to correct for participant motion and
image distortions due to eddy currents. The diffusion vector was also
corrected for participant motion, based on the output of the eddy cur-
rent correction. The diffusion tensor was ﬁt to each voxel using DTIFIT.
The data was then brain extracted using BET (Smith, 2002). The
resulting FA, mean diffusivity (MD), radial diffusivity (RD), and axial
diffusivity (AD) maps were input into tract-based spatial statistics
(TBSS) (Smith et al., 2006; Smith et al., 2007). In TBSS, all subjects' FA
data are aligned into a common space (registration target: FMRIB58_FA
1 mm) using the nonlinear registration tool FNIRT (Andersson et al.,
2007a; Andersson et al., 2007b; Rueckert et al., 1999). For each patient,
a binary exclusion mask representing voxels that were identiﬁed as
lesions (see Section 2.3.2.1) was input to FNIRT to avoid excessive
warping in lesioned brain areas. Next, the mean FA image was created
and thinned to create a mean FA skeleton which represents the centers
of all tracts common to all participants. Each participant's aligned FA
data were then projected onto this skeleton (thresholded at FA N .3).
The MD, RD, and AD maps were transformed to standard space (using
the warps deﬁned based on the FA maps as described above), and
projected onto the thresholded FA skeleton.
The resulting FA, MD, RD, and AD data were input into voxel-wise
cross-subject statistics. We evaluated the statistical signiﬁcance of
between-group differences in FA,MD, RD, andAD, aswell as correlations
between theseDTImetrics and behavioral performance on all three CTIP
subtests, for both mean reaction time (RT) and ISD (calculated as de-
scribed in Section 2.2.2.2). We also evaluated the relation between
SDMT score and DTI metrics. To do so, voxel-wise permutation tests
were performed (Nichols and Holmes, 2002), as implemented by FSL's
randomise software (5000 permutations, p b .01, corrected for multiple
comparisons using threshold-free cluster enhancement (Smith and
Nichols, 2009)). Each behavioral measure was modeled separately,
with one covariate for each group. Agewas included in all TBSS analyses
as a covariate of no interest. Regressors were mean-centered before
being input to the analyses.
2.3.2.3. Regions of interest. Both TBSS and lesion data were considered
with respect to 16 regions of interest (ROIs) from the JHU ICBM-
DTI-81 white matter labels atlas in FSL (Mori et al., 2008) (see
Appendix A). The lesion load of each region was calculated based on
the percentage of voxels in the ROI that were classiﬁed as lesions in
the group lesion map. To evaluate TBSS results with respect to each
ROI, the number of FA skeleton voxels in each ROI was determined.
An ROI was considered related to a particular measure if greater
than or equal to 40% of its skeleton voxels showed a signiﬁcant effect
in the TBSS analysis (threshold based on (Yu et al., 2012)).
3. Results
3.1. Clinical measures
Demographic, clinical, and test result data for the MS and control
participant groups are presented in Table 1. The MS participants'
Table 2
Correlation analysis between behavioral measures and BPF and lesion volume (fraction
of total parenchymal volume) for the MS participant group.
Behavioral measure BPF Lesion load
R p R p
aSDMT 0.405 0.085 −0.533 0.019
bCTIP-SRT Mean −0.582 0.009 0.536 0.018
bCTIP-CRT Mean −0.156 0.524 0.458 0.048
bCTIP-SSRT Mean −0.528 0.020 0.596 0.007
bCTIP-SRT ISD −0.484 0.036 0.633 0.004
bCTIP-CRT ISD −0.161 0.510 0.222 0.362
bCTIP-SSRT ISD −0.314 0.190 0.487 0.019
a Higher scores indicate better performance.
b Higher scores indicate worse performance.
897E.L. Mazerolle et al. / NeuroImage: Clinical 2 (2013) 894–902median EDSS score was 2.25 (range: 1–3.5). MS participants did not
report signiﬁcantly higher levels of depression than controls and did
not differ from controls on the basis of age or years of education.
3.2. Tests of information processing speed
The test results for the SDMT and CTIP subtests are summarized in
Table 1. While MS participants obtained somewhat lower scores than
controls on the SDMT, the group difference was not statistically sig-
niﬁcant (t(38) = 1.73, p = .09). Accuracy data is not recorded for the
SRT. Both MS participants and controls performed the CRT and SSRT
with 98% accuracy (mean ± standard deviation; CRT: MMS = 29.45 ±
.83; MControls = 29.65 ± .74; SSRT: MMS = 29.45 ± .83; MControls =
29.65 ± .74). MS participants had signiﬁcantly longer mean RTs on
both the SRT (t(37.8) = 2.8; p b .01) and SSRT (t(38) = 3.2;
p b .005), but not on the CRT (t(38) = 1.6; p = .12).
As with the mean RT results, MS participants demonstrated larger
ISDs (i.e., worse performance) on the SRT (t(38) = 3.03; p b .005)
and the SSRT subtests (t(38) = 2.8; p b .01), though not on the CRT
subtest (t(38) = .9; p = .38).
Correlations between pairs of behavioral measures were exam-
ined for the MS participant group only. SDMT scores were not signif-
icantly correlated with mean RT on the SRT subtest of the CTIP
(r = − .40; p = .09) but were correlated with both CRT (r = − .52;
p b .05) and SSRT (r = − .57; p b .01) mean RT. SDMT scores were
also correlated with ISD for the SSRT subtest of the CTIP (r = − .45;
p b .05), though not with ISD for the SRT (r = − .31; p = .19) or
CRT (r = − .21; p = .39) subtests.
3.3. Atrophy and lesions
3.3.1. Group differences
Brain parenchyma fraction (BPF; mean ± standard deviation) was
signiﬁcantly lower in MS patients (81.8 ± 2.9%) than controls
(84.4 ± 2.1%; t(38) = 3.24; p b .005). The mean lesion load of
the MS patients was 15.8 ± 24.5 ml, which was equivalent to
1.2 ± 1.9% of total intracranial volume, or 1.6 ± 2.5% of total paren-
chymal volume.
3.3.2. Relations to behavioral measures
The relations between behavioral measures, BPF, and lesion vol-
ume (fraction of total parenchymal volume) were examined for the
MS patients only (Table 2). SDMT performance was not signiﬁcantly
correlated with BPF, but was correlated with lesion volume. BPF was
correlated with mean performance on the SRT and SSRT subtests of
the CTIP, while for ISD this correlation was signiﬁcant only for theTable 1
Demographic information, clinical measures, and information processing speed test re-
sults for the MS and control groups (mean ± standard deviation except where indicat-
ed otherwise).
MS participants Control participants p
Na 20 20
Age (years) 42.4 ± 6.3 42.5 ± 7.8 n.s.
Education (years) 14.6 ± 1.8 15.1 ± 2.3 n.s.
EDSSb 2.25 n/a
Disease duration (years) 8.1 ± 6.9
BDI-Fast Screen 1.8 ± 2.1 1.1 ± 1.5 n.s
SDMT (# of correct responses) 54.4 ± 11.2 60.4 ± 10.7 n.s.
SRT (msc) 410.4 ± 63.8 351.5 ± 68.5 b .01
CRT (ms) 664.2 ± 121.4 592.4 ± 163.0 n.s.
SSRT (ms) 1000.2 ± 179.8 819.9 ± 176.3 b .005
SRT (ISD) 8.2 ± 3.0 5.7 ± 2.0 b .005
CRT (ISD) 8.2 ± 2.5 7.4 ± 2.9 n.s.
SSRT (ISD) 9.3 ± 2.2 7.6 ± 1.9 b .01
a Total.
b Median.SRT subtest. Lesion volume was correlated with both mean perfor-
mance and ISD on the SRT and SSRT subtests, as well as with mean
performance on the CRT subtest.
The ROI analysis of group level lesion volumes is presented in
Table 3. In this sample of MS participants, lesion load was most pro-
nounced in the corona radiata and posterior thalamic radiation, with
greater than 25% of voxels in these ROIs identiﬁed as lesions. Lesions
were also observed in the sagittal stratum, superior frontal–occipital
fasciculus, superior longitudinal fasciculus, the corpus callosum (body,
genu, and splenium), and internal capsule ROIs.
3.4. DTI
3.4.1. Group differences
TBSS analysis revealed group differences in all DTI metrics across
numerous regions of white matter, with lower FA and higher diffusiv-
ity (MD, RD, and AD) in MS participants compared to controls. No ex-
amples of the reverse (i.e., higher FA and/or lower diffusivity in
MS participants) were observed in our sample. Suprathreshold effects
(i.e., signiﬁcant TBSS results in N40% of skeletal voxels in the ROI (Yu
et al., 2012)) were observed in the sagittal stratum, the superior lon-
gitudinal fasciculus, the corpus callosum (body, genu, and splenium),
the corona radiata, and the posterior thalamic radiation (Table 3).
Fig. 1 displays signiﬁcant group differences in FA as determined by
TBSS analysis, overlaid on the group lesion map. Note that the TBSS
analysis revealed greater percentages of affected tissue than the
group level lesion volume analysis (Table 3), withmicrostructural dif-
ferences between MS patients and controls extending beyond regions
identiﬁed as lesions into areas of NAWM. The increased percentage of
affected ROI for DTI metrics relative to lesion burden is highlighted in
Fig. 2, which depicts the group differences in FA and group lesion map
in the splenium of the corpus callosum — an example of an ROI with
limited lesions but extensive FA differences between MS patients and
controls.
3.4.2. Relations to behavioral measures
The ROI analysis of the correlations between behavioral measures
and DTI metrics of the MS participants, as determined by TBSS, is
summarized in Table 4. Each behavioral measure was modeled
separately, with one covariate for each group. As described in
Section 2.2.2.2, the ISD calculation uses regression to parcel out sys-
tematic factors that can affect variability, and ensures that differences
in variability are not a statistical artifact of differences in individual or
group mean performance (Hultsch et al., 2000). No suprathreshold
relations were observed for the CRT or SSRT, for either mean-level
performance or ISD (data not shown). For control participants, no
voxels demonstrated signiﬁcant relations between any DTI metric
and any behavioral measure (data not shown).
For MS patients, numerous relations between DTI metrics and be-
havioral measures were observed. In all instances, worse perfor-
mance on behavioral measures was associated with decreased FA or
Table 3
ROI analysis of group-level lesion ﬁndings and group differences on the DTI metrics evaluated using TBSS. For the TBSS analyses, bold font indicates ROIs that are suprathreshold
(see Section 2.3.2 for details).
Tract Lesions FA (MS b C) MD (MS N C) RD (MS N C) AD (MS N C)
% of total ROI % of skeletal ROI % of skeletal ROI % of skeletal ROI % of skeletal ROI
Cingulum 0.0 14.9 12.1 24.6 1.7
External capsule 0.0 26.3 17.1 15.3 13.7
Fornix 0.0 0.0 0.0 0.0 0.0
Sagittal stratum 13.4 84.7 73.6 83.5 27.2
Superior frontal–occipital fasciculus 8.7 0.0 11.2 0.0 28.4
Superior longitudinal fasciculus 16.0 20.5 53.6 35.2 25.5
Uncinate fasciculus 0.0 0.0 2.2 0.0 1.5
Cerebral peduncle 0.0 9.5 0.0 0.0 0.4
Corticospinal tract 0.0 0.0 0.0 0.0 0.0
Medial lemniscus 0.0 0.0 0.0 0.0 0.0
Corpus callosum (body) 4.9 74.4 72.6 78.9 39.1
Corpus callosum (genu) 8.8 29.1 49.9 33.1 35.6
Corpus callosum (splenium) 3.4 72.8 88.0 82.8 61.8
Corona radiata 34.7 40.8 69.0 54.4 50.3
Internal capsule 1.4 15.6 29.5 16.5 31.8
Posterior thalamic radiation 27.4 83.4 75.4 88.0 33.8
MS: multiple sclerosis participant group.
C: control participant group.
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metrics for the body (FA) and genu (FA, MD, RD) of the corpus
callosum, the posterior thalamic radiation (FA, MD, RD), and the su-
perior longitudinal fasciculus (MD, RD). Mean CTIP SRT performance
was associated with DTI metrics for the body (FA, MD, RD), genu
(FA, MD, RD), and splenium (MD) of the corpus callosum, as well as
for the posterior thalamic radiation (RD), the uncinate fasciculus
(FA), and the corona radiata (RD). ISD on the SRT subtest of the
CTIP was associated with DTI metrics in the greatest number of
white matter ﬁber tracts. These again included the body (FA, MD,
RD), genu (FA, MD, RD), and splenium (MD, AD) of the corpus
callosum, as well as the posterior thalamic radiation (MD, RD), the
uncinate fasciculus (FA), the corona radiata (MD, RD), and the superi-
or longitudinal fasciculus (MD). In addition, associations of ISD were
found for the external capsule (FA) and the superior frontal–occipital
fasciculus (AD) that were not seen for either SDMT or mean CTIP SRT
performance.
4. Discussion
Consistent with previous studies, we identiﬁed regions of reduced
FA and increased diffusivity in the white matter of MS patientsFig. 1. Group lesion map and signiﬁcant group differences (MS participants b controls) in F
with the z-positions of selected slices shown. Images are displayed using radiological convrelative to matched controls (Table 3; e.g., (Roosendaal et al., 2009;
Kern et al., 2011; Yu et al., 2012; Onu et al., 2012; Bozzali et al.,
2013)). The regions of reduced FA extended beyond lesions into
NAWM (Figs. 1 and 2), conﬁrming previous assertions regarding the
greater sensitivity of DTI to MS-related white matter pathology relative
to conventional MRI (e.g., (Roosendaal et al., 2009; Yu et al., 2012)). De-
spite the mild neurologic disability of our sample, we also observed re-
duced BPF in MS patients relative to controls, a ﬁnding also seen in
previous studies of early stage or mildly affected relapsing–remitting
MS patients (Chard et al., 2002; De Stefano et al., 2007).
SDMT performance was not signiﬁcantly correlated with BPF
(Table 2), a ﬁnding consistent with that of a previous study in
which a broader range of clinical cognitive tests were examined
(Sastre-Garriga et al., 2009). In contrast, we did observe a relation be-
tween SDMT performance and lesion burden (Table 2). Previous stud-
ies have producedmixed evidence with some studies having reported
either no relation or a non-signiﬁcant trend (Bomboi et al., 2011;
Brochet et al., 2008), whereas other studies have reported a signiﬁ-
cant relation between lesion burden and SDMT performance for per-
sons with MS (Rovaris et al., 2002; Stankiewicz et al., 2011).
TBSS analysis revealed that, for MS patients, white matter micro-
structural measures were correlated with SDMT performance in theA based on the TBSS analysis. Results are overlaid on the mean FA image, in MNI space,
ention.
Fig. 2. Example of an ROI with minimal lesions, but widespread FA differences between
MS participants and controls (splenium of the corpus callosum). Note that the TBSS
analysis of FA was restricted to FA skeleton voxels (not shown; see Section 2.3.2.2
for details), whereas the group lesion map was not restricted. Top left: coronal section;
top right: sagittal section; bottom left: axial section. Images are displayed using radio-
logical convention.
899E.L. Mazerolle et al. / NeuroImage: Clinical 2 (2013) 894–902superior longitudinal fasciculus, corpus callosum, and posterior tha-
lamic radiation (Table 4). These ﬁndings were also observed by Yu
et al. (2012), who further identiﬁed the external capsule, cingulum,
sagittal stratum, fornix, uncinate fasciculus, corona radiata, internal
capsule, and cerebral peduncle as related to SDMT performance. To
our knowledge, no other studies have used a voxel-based approach
to evaluate the relation between microstructure and SDMT perfor-
mance in MS; however, previous studies have demonstrated correla-
tions between SDMT performance and FA within an ROI of the
midsagittal corpus callosum (de Medeiros Rimkus et al., 2011) and
for the whole brain (Warlop et al., 2009). Thus, our ﬁndings add toTable 4
Results of the TBSS analysis for the SDMT, CTIP-SRT mean, and CTIP-SRT ISD, for the MS parti
with worse performance. Bold font indicates ROIs for which suprathreshold relations were
% of skeletal voxels in ROI with signiﬁcant effe
SDMT
Tract FA MD RD AD
Cingulum 15.2 3.2 8.2 0.0
External capsule 30.3 19.7 22.8 15.2
Fornix 0.0 0.0 0.0 0.0
Sagittal stratum 27.5 21.9 33.0 0.0
Superior frontal–occipital fasciculus 0.0 0.0 0.0 0.0
Superior longitudinal fasciculus 37.4 40.4 41.4 0.0
Uncinate fasciculus 14.1 12.6 16.3 7.4
Cerebral peduncle 0.0 0.0 0.0 0.0
Corticospinal tract 0.0 0.0 0.0 0.0
Medial lemniscus 0.0 0.0 0.0 0.0
Corpus callosum (body) 40.5 16.9 37.1 0.0
Corpus callosum (genu) 79.6 42.7 71.6 0.0
Corpus callosum (splenium) 32.9 34.1 33.8 0.0
Corona radiata 27.1 18.5 26.0 0.3
Internal capsule 1.8 3.4 3.2 0.0
Posterior thalamic radiation 59.7 54.9 60.9 3.7the limited available evidence suggesting that DTI metrics of white
matter integrity are indeed sensitive to information processing
speed, as measured by standard clinical tests, among mildly affected
MS patients.
To our knowledge, ours is the ﬁrst investigation of the relations
between CTIP performance and structural brain imaging measures.
Mean performance and IIV on CTIP subtests, particularly the SRT
subtest, were related with both BPF and lesion load (Table 2). Fur-
thermore, mean performance and IIV on the SRT subtest of the CTIP
were signiﬁcantly related to DTI measures (Table 4). Mean perfor-
mance on the SRT subtest of the CTIP was signiﬁcantly associated
with DTI microstructural measures in the corpus callosum, the poste-
rior thalamic radiation, the uncinate fasciculus and the corona radiata.
While IIV on the SRT subtest was associated with DTI microstructural
measures in these same regions, additional associations were found
for the superior longitudinal fasciculus, the external capsule, and
the superior frontal–occipital fasciculus.
In contrast to the SRT subtest, neither the CRT nor SSRT subtests had
suprathreshold relationswith DTImetrics, for eithermean performance
or IIV. Based on the current data, it is not clear why performance on the
CRT or SSRT CTIP subtests was not also related to white matter micro-
structure. Differences in task demands might be an explanatory factor,
as both the CRT and SSRT subtests require choosing between bimanual
responses (i.e., participants must respond using one of two buttons)
whereas the SRT requires only a unimanual response. Thus the CRT
and SSRT subtests are more complex in their response requirements
and are more cognitively demanding than the SRT subtest of the CTIP.
While the SDMT could also be considered cognitively demanding, and
conversely was associated with suprathreshold relations with DTI met-
rics, the SDMT has numerous other features that differ from the CTIP
subtests, such as requiring a verbal rather than a manual response. It
is possible that methods characterizing macrostructure and/or gray
matter may be sensitive to neurologic correlates of CRT and SSRT per-
formance that are not evidentwhen using the TBSS approach employed
in the current study. IIV on more cognitively demanding tasks might
also be better characterized by examining functional connectivity
(e.g., (Wojtowicz et al., 2012b)) and it seems likely that a comprehen-
sive understanding of the neural correlates of IIV will require a multi-
modal imaging approach.
Speculations regarding the mechanisms of the link between IIV
and white matter microstructure have been previously proposed
based on data from healthy adults. In this context, it has been sug-
gested that IIV reﬂects neural noise and disruptions of action poten-
tials associated with decreased white matter integrity (Fjell et al.,cipant group. In all cases, decreased FA and/or increased MD, RD, and AD was associated
observed (see Section 2.3.2 for details).
ct in the TBSS analysis
CTIP-SRT mean CTIP-SRT ISD
FA MD RD AD FA MD RD AD
16.6 4.2 9.6 0.0 14.6 9.8 17.4 0.5
30.1 30.6 38.3 0.0 54.9 39.7 37.5 0.4
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
16.5 26.1 30.6 0.0 32.0 30.9 36.9 0.0
0.0 19.0 0.9 0.0 0.0 25.9 19.0 42.2
1.9 10.0 19.5 0.0 1.7 40.6 24.4 31.0
43.7 11.9 27.4 0.0 70.4 11.9 33.3 0.0
1.6 0.0 0.6 0.0 0.1 0.5 1.6 11.6
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
55.7 41.3 57.7 0.0 47.9 49.7 60.0 28.4
65.1 50.8 61.5 0.0 70.3 67.7 73.9 31.7
13.7 41.2 31.0 0.0 6.6 43.2 27.4 65.1
33.2 33.6 46.9 0.3 37.1 54.7 54.5 31.0
2.4 6.1 6.2 1.1 4.0 16.2 8.5 31.4
20.8 39.5 46.8 0.7 22.9 43.8 50.2 14.3
Total volume and FA skeleton volume for the 16 ROIs investigated.
Tract Category ROI volume (ml)
Total FA skeleton
Cingulum Association ﬁbers 7484 1293
External capsule Association ﬁbers 11,198 2557
Fornix Association ﬁbers 659 103
Sagittal stratum Association ﬁbers 4459 1036
Superior frontal–occipital fasciculus Association ﬁbers 1014 116
Superior longitudinal fasciculus Association ﬁbers 13,212 2838
Uncinate fasciculus Association ﬁbers 756 135
Cerebral peduncle Brainstem tract 4556 1278
Corticospinal tract Brainstem tract 2732 619
Medial lemniscus Brainstem tract 1389 96
Corpus callosum (body) Commissural ﬁbers 13,711 3263
Corpus callosum (genu) Commissural ﬁbers 8851 1755
Corpus callosum (splenium) Commissural ﬁbers 12,729 2590
Corona radiata Projection ﬁbers 36,151 7646
Internal capsule Projection ﬁbers 18,646 4827
Posterior thalamic radiation Projection ﬁbers 7950 2154
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ifestations of response variability versus response slowing remain in-
completely characterized, IIV may be the more sensitive indicator of
white matter integrity as behavioral instabilities associated with neu-
ral noise become less evident when performance is averaged across
trials.
To our knowledge, our study provides the ﬁrst demonstration of a
relation between intra-individual performance variability and DTI
metrics in persons with MS. We demonstrated that, for our sample
of mildly affected MS participants, increased IIV on the SRT subtest
of the CTIP was associated with reduced integrity of multiple white
matter regions, as measured by DTI. These results suggest that IIV
may be a sensitive behavioral marker for neurologic dysfunction;
consistent with ﬁndings of increased IIV in other neurologic disorders
(reviewed in MacDonald et al. (2006) and MacDonald et al. (2009).
Our results imply that greater IIV is associated with reduced structur-
al connectivity due to disease-related reductions in white matter
integrity.
Increased IIV was associated with reduced white matter integrity
in more tracts than either SDMT performance or mean performance
on the SRT subtest of the CTIP. These ﬁndings provide preliminary ev-
idence that IIV may be sensitive to a broader range of MS-related dif-
ferences in tissue microstructure than are more commonly used tests
of information processing speed. This link between IIV and white
matter microstructure provides a possible neurologic basis for the
ﬁndings of prior behavioral studies which reported that IIV was
better able to discriminate MS patients from healthy controls than
mean-level performance on timed tests (Bodling et al., 2012;
Wojtowicz et al., 2012a; Wojtowicz et al., 2013). However, more re-
search is needed into the neurologic correlates of IIV using larger
and more representative samples of MS patients. In particular, exam-
ining the reproducibility of the current results with respect to the
particular tracts implicated for each behavioral measure would pro-
vide valuable insight into understanding how the different white
matter regions contribute to the overall neurologic and cognitive sta-
tus of the patient.
More generally, our ﬁnding that IIV was sensitive to microstruc-
tural measures in more regions than mean-level performance high-
lights the potential that IIV holds for improving our understanding
of the brain–behavior relationship. This sentiment is in line with re-
cent studies of healthy individuals in which white matter integrity
was linked to IIV in reaction time more so than mean reaction time
on a ﬂanker task (Fjell et al., 2011; Tamnes et al., 2012). Indeed, focus-
ing on mean-level performance may be an oversimpliﬁcation, partic-
ularly when studying persons with high IIV, such as neurological
populations (MacDonald et al., 2009). Thus, there is mounting evi-
dence that evaluating the distribution of behavioral responses (as op-
posed to evaluating mean-level performance only) will allow the
neural basis of behavior to be better characterized.
Our study is subject to a number of limitations, including restric-
tions in our subject recruitment to mildly affected MS participants.
Also, the CTIP includes only 30 trials per subtest and while previous
studies of IIV have used similar numbers of test trials (e.g., (Burton
et al., 2006; Dixon et al., 2007)) estimates of IIV might be improved
by including more trials. We also considered only one measure of
central tendency (mean) and one measure of variability (ISD) in
this study. Although we have previously found that ISD better dis-
criminated MS patients from controls than did coefﬁcient of variation
(Wojtowicz et al., 2012a), evaluating other measures of central
tendency (e.g., median) as well as variability will be important for
verifying the relative importance of IIV as a measure of cognitive dys-
function in MS.
The data analysis approach that we adopted in the current study
modeled the behavioral measures as separate covariates for the two
groups. We did not observe signiﬁcant relations between DTI metrics
and behavioral measures in the control group, suggesting that theeffects we observed are related to MS. However, studies of larger
samples of healthy controls with a broader age range might reveal re-
lations between DTI metrics and CTIP performance (e.g., (Fjell et al.,
2011)). We also opted to analyze mean performance and IIV
(corrected for individual mean performance) in separate models.
This approach provides greater sensitivity and was important for
this initial investigation, although it limits our ability to determine
the relative importance of the two variables. Multiple DTI metrics
were evaluated in this study (FA, MD, RD, and AD) and while there
is evidence from animal models that different DTI metrics have dis-
tinct physiological bases (e.g., radial diffusivity reﬂects myelin con-
tent (Song et al., 2002)), there remain outstanding issues to be
resolved before these concepts can be applied to human studies
(Wheeler-Kingshott and Cercignani, 2009). The goal of including
multiple DTI metrics in our analyses was not to evaluate which phys-
iological parameters relate to cognition, but rather to improve our
sensitivity by capitalizing on the additional (albeit non-unique) infor-
mation provided by each metric. Thus, we did not attempt to specu-
late on the speciﬁc physiological underpinnings of the DTI metrics
used.
5. Conclusions
We demonstrated that mean performance and IIV on the CTIP are
sensitive to neurologic manifestations of MS, including lesion burden,
BPF, and DTI indices of white matter microstructure, even among
mildly affected persons. In particular, our report highlights the poten-
tial value of considering metrics of within-person ﬂuctuations in per-
formance speed, in addition to mean-level performance, for exploring
relationships between behavior and white matter integrity.
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